Objective A new class of reagents for directly accessing more drug like molecules at the early stages of drug development will be developed. This technology is based on a new method to easily prepare saturated N-heterocycles, which have proven advantages in drug like molecules but are difficult to prepare at the early stages of lead discovery and optimization. The key reactions and reagent has been validated and partners for distribution and test marketing established. The ERC PoC funding will support a first delivery of the reagents and support the development of new reagent classes in consultation with key industry leaders. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery Programme(s) FP7-IDEAS-ERC - Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Topic(s) ERC-OA-2013-PoC - European Research Council ERC Proof of Concept Call for proposal ERC-2013-PoC See other projects for this call Funding Scheme CSA-SA(POC) - Supporting action (Proof of Concept) Host institution EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH EU contribution € 149 528,00 Address Raemistrasse 101 8092 Zuerich Switzerland See on map Region Schweiz/Suisse/Svizzera Zürich Zürich Activity type Higher or Secondary Education Establishments Administrative Contact Jeffrey William Bode (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Beneficiaries (1) Sort alphabetically Sort by EU Contribution Expand all Collapse all EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH Switzerland EU contribution € 149 528,00 Address Raemistrasse 101 8092 Zuerich See on map Region Schweiz/Suisse/Svizzera Zürich Zürich Activity type Higher or Secondary Education Establishments Administrative Contact Jeffrey William Bode (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data
